about
Imaging of Organ Metabolism in Obesity and Diabetes: Treatment Perspectives.Metabolic imaging in obesity: underlying mechanisms and consequences in the whole body.Increased brain fatty acid uptake in metabolic syndromeBrain glucose overexposure and lack of acute metabolic flexibility in obesity and type 2 diabetes: a PET-[18F]FDG study in Zucker and ZDF ratsWaist circumference adjusted for body mass index and intra-abdominal fat mass.Effects of insulin on brain glucose metabolism in impaired glucose tolerance.Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy.Myocardial metabolic and receptor imaging in idiopathic dilated cardiomyopathy.Impact of obesity on the expression profile of natriuretic peptide system in a rat experimental model.Obesity-associated intestinal insulin resistance is ameliorated after bariatric surgeryDevelopmental determinants in non-communicable chronic diseases and ageing.Fatty heart, cardiac damage, and inflammation.Seeing is believing: dietary fatty acids hurry up from the stomach to the heart of patients with impaired glucose tolerance.Myocardial, perivascular, and epicardial fatm.3243A>G mutation in mitochondrial DNA leads to decreased insulin sensitivity in skeletal muscle and to progressive beta-cell dysfunction.Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids(11)C-meta-hydroxyephedrine PET/CT imaging allows in vivo study of adaptive thermogenesis and white-to-brown fat conversion.Non-invasive estimation of hepatic blood perfusion from H2 15O PET images using tissue-derived arterial and portal input functions.Exercise restores skeletal muscle glucose delivery but not insulin-mediated glucose transport and phosphorylation in obese subjects.The association of micronucleus frequency with obesity, diabetes and cardiovascular disease.Brain PET imaging in obesity and food addiction: current evidence and hypothesis.Developmental ORIgins of Healthy and Unhealthy AgeiNg: the role of maternal obesity--introduction to DORIAN.Chronic primary hyperinsulinaemia is associated with altered insulin receptor mRNA splicing in muscle of patients with insulinoma.Cross-Talk Between Adipose Tissue Health, Myocardial Metabolism and Vascular Function: The Adipose-Myocardial and Adipose-Vascular Axes.Endothelin system mRNA variation in the heart of Zucker rats: evaluation of a possible balance with natriuretic peptides.Rate of telomere shortening and metabolic and cardiovascular risk factors: a longitudinal study in the 1934-44 Helsinki Birth Cohort Study.Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance.Increased nonoxidative glucose metabolism in idiopathic reactive hypoglycemia.Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals.Contribution of glucose tolerance and gender to cardiac adiposity.Higher free fatty acid uptake in visceral than in abdominal subcutaneous fat tissue in men.Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis.Effects of acute and one-week fatty acid lowering on cardiac function and insulin sensitivity in relation with myocardial and muscle fat and adiponectin levels.Validation of [18F]fluorodeoxyglucose and positron emission tomography (PET) for the measurement of intestinal metabolism in pigs, and evidence of intestinal insulin resistance in patients with morbid obesity.Assessment of infarct size by positron emission tomography and [18F]2-fluoro-2-deoxy-D-glucose: a new absolute threshold technique.Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans.Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance.Mismatch between insulin-mediated glucose uptake and blood flow in the heart of patients with Type II diabetes.Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humans.Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control.
P50
Q30804205-7B4D5E35-A0B1-418F-84A7-38B2D4DBBB35Q30991322-6C523FDA-F868-4B9A-BE09-683FCFFD4857Q34082813-C2EE33C5-D1B6-4722-84E6-2EF18605964EQ34171065-B9BE4A2C-4997-4244-B797-45FC4DD898EAQ34182363-0C5D549C-EECB-4B3C-BF8F-F4EC4115D852Q34527026-E87BE8FC-A07F-4142-B3B9-9BCDBF35BC48Q34819581-454E0647-38D6-4C96-B035-E85FC262025DQ34884131-D40ECA0B-06F7-4A6C-9F0A-4CFA320E6D45Q34979675-27979E5A-B29F-45AB-8006-F8E5069A7B17Q35350002-030393B3-1900-438C-829B-FBBF4F3B4354Q35577806-AB966229-AD94-4209-B4B3-739C13515F75Q35760308-4D8B5A61-B76D-4896-BEF3-A50025030136Q36339509-7DA40B5D-1591-4C19-999C-5F7F9AF63644Q36783911-C74263FB-3C45-4131-B42B-43C0805A53B2Q37105289-1D55B8B5-AFB3-4386-9EF8-E02A8177298AQ37150162-31341E1F-2827-4172-A340-573BB6FED183Q37173356-2CEEE0F6-E30E-4D65-B786-4954487E2100Q37336123-7A11FB3E-11F2-4E04-A7A9-3BF311DEC1F3Q37346508-EF5CC09F-AF3C-43B6-8221-9D2D7F7B29A3Q37821660-460D2B20-FB56-4CC2-BFED-991F9F9508D8Q38014596-9B128557-04FC-4A33-89A3-3913546A4B0CQ38209730-1D4F7DA0-1077-4EC7-A744-7B858A44479EQ38362229-5DB555E6-6296-4FA8-AA7C-3ACEE42A0B9CQ38627960-DD98E958-0CF4-4DD7-867D-A6ECDDBD6B0DQ39161412-5C107505-A0B1-43FE-A665-2D62AAB94982Q41412544-A247945C-08EC-49E7-83C8-C955FB126101Q42469370-6E8BCFCA-6998-49FA-83AF-E19926D9FB08Q42517148-8EE3C3BF-3BC1-4F6A-B24E-C4D7801BB29BQ42946610-7A9F3748-77C4-43F4-B953-BB49EF746851Q43263764-10DFCA4D-E319-4C48-97BB-6B8131882766Q43288463-28B49CAC-E7C6-4E9F-BDA7-13706B86463DQ43565222-C8984508-292B-4750-B621-589CA086F0D7Q43670976-55DC3E19-42A6-4E36-B432-CE4AE42B5D40Q43777775-0C41AAB3-778F-4DC4-85C4-E15A3ADAB41FQ43945839-62F8B1BE-D205-48FE-B94B-CFB3A2570ACEQ43948719-E27933B5-5065-4D4B-A70E-DF19565ED0BAQ44155540-840907F3-FA0A-4566-A7AD-9C7FDFDCF3F2Q44178336-D509321D-1276-4187-8939-F6C6710476E5Q44200139-79973930-FFF9-4B20-BF35-452771FF2947Q44427449-E05EB624-971A-4C40-A83D-8C26458C8BD1
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Patricia Iozzo
@ast
Patricia Iozzo
@en
Patricia Iozzo
@es
Patricia Iozzo
@nl
Patricia Iozzo
@sl
type
label
Patricia Iozzo
@ast
Patricia Iozzo
@en
Patricia Iozzo
@es
Patricia Iozzo
@nl
Patricia Iozzo
@sl
prefLabel
Patricia Iozzo
@ast
Patricia Iozzo
@en
Patricia Iozzo
@es
Patricia Iozzo
@nl
Patricia Iozzo
@sl
P1053
O-2893-2015
P106
P21
P31
P3829
P496
0000-0001-6443-7074